Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 75

Results For "MD"

1112 News Found

Piramal Pharma expands API capabilities at Digwal
News | June 15, 2022

Piramal Pharma expands API capabilities at Digwal

Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies


Thermo Fisher Scientific launches new MS-based solutions
News | June 14, 2022

Thermo Fisher Scientific launches new MS-based solutions

Thermo Scientific Direct Mass Technology mode augments Thermo Scientific Q Exactive UHMR Hybrid Quadrupole-Orbitrap mass spectrometers with charge detection capabilities


Quizartinib Plus chemotherapy significantly improved overall survival compared to chemo
News | June 12, 2022

Quizartinib Plus chemotherapy significantly improved overall survival compared to chemo

Doubling of median overall survival seen in QuANTUM-First results presented at EHA Presidential Symposium


TaCa Healthcare expands its operations to Telangana and Andhra Pradesh
Healthcare | June 11, 2022

TaCa Healthcare expands its operations to Telangana and Andhra Pradesh

Plans to establish six state of the art TaCa Centre for Surgery in next 2 years in these states


Takeda’s dengue vaccine candidate offers protection against dengue fever in clinical trial
Diagnostic Center | June 11, 2022

Takeda’s dengue vaccine candidate offers protection against dengue fever in clinical trial

TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union


Novartis Tafinlar and Mekinist demonstrates unprecedented efficacy in pediatric patients
News | June 08, 2022

Novartis Tafinlar and Mekinist demonstrates unprecedented efficacy in pediatric patients

If approved, Tafinlar + Mekinist may offer a potential new standard-of-care for pediatric patients with this brain cancer


Eugia Pharma receives USFDA Approval for Leuprolide Acetate Injection
Drug Approval | June 08, 2022

Eugia Pharma receives USFDA Approval for Leuprolide Acetate Injection

he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.


Novartis Scemblix shows better result for chronic myeloid leukemia trial
Diagnostic Center | June 08, 2022

Novartis Scemblix shows better result for chronic myeloid leukemia trial

Scemblix (asciminib) continues to show superior efficacy with more-than-two-fold improvement in major molecular response rate vs. Bosulif (bosutinib) at 96 weeks


APhA appoints Ilisa Bernstein Interim CEO
People | June 06, 2022

APhA appoints Ilisa Bernstein Interim CEO

Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA


Aurobindo Pharma Q4 PAT drops 28% to Rs 576 Cr
News | June 06, 2022

Aurobindo Pharma Q4 PAT drops 28% to Rs 576 Cr

Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore